COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020 - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Emerging Infectious Diseases Année : 2020

COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

Résumé

Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations.

Dates et versions

hal-03373197 , version 1 (11-10-2021)

Licence

Paternité

Identifiants

Citer

Francois Benezit, Audrey Le Bot, Stéphane Jouneau, Florian Lemaitre, Charlotte Pronier, et al.. COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020. Emerging Infectious Diseases, 2020, 26 (10), pp.2513-2515. ⟨10.3201/eid2610.201816⟩. ⟨hal-03373197⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More